These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 203028

  • 21. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A.
    Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract] [Full Text] [Related]

  • 22. Hyperlipoproteinemia. Some basic concepts on diagnosis and management.
    Levy RI.
    JAMA; 1973 Nov 05; 226(6):648-9. PubMed ID: 4356846
    [No Abstract] [Full Text] [Related]

  • 23. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC.
    Pharmacotherapy; 1995 Nov 05; 15(3):317-37. PubMed ID: 7667166
    [Abstract] [Full Text] [Related]

  • 24. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983 Nov 05; 33(5):776-9. PubMed ID: 6683558
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W, Reuter W.
    Z Gesamte Inn Med; 1982 Dec 15; 37(24):830-3. PubMed ID: 6963524
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
    Vessby B, Lithell H, Gustafsson IB, Borberg J.
    Atherosclerosis; 1979 Aug 15; 33(4):457-77. PubMed ID: 228684
    [Abstract] [Full Text] [Related]

  • 29. [Therapy of hyperlipoproteinemia type IIa, IIb and IV with Etofibrate retard].
    Schwartzkopff W, Schilling A, Calder D.
    Med Welt; 1980 Apr 04; 31(14):515-20. PubMed ID: 7374415
    [No Abstract] [Full Text] [Related]

  • 30. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM, Levy RI.
    Cardiovasc Clin; 1974 Apr 04; 6(2):1-8. PubMed ID: 4374303
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Familial hyperlipidemias. Diagnosis and treatment.
    Fleischmajer R, Dowlati Y, Reeves JR.
    Arch Dermatol; 1974 Jul 04; 110(1):43-50. PubMed ID: 4371196
    [No Abstract] [Full Text] [Related]

  • 33. [Constellation of lipoproteins in patients with hyperlipoproteinemia and in rabbits fed a cholesterol diet with reference to vascular permeability].
    Herrmann W, Reuter W.
    Z Gesamte Inn Med; 1977 Dec 15; 32(24):682-2. PubMed ID: 204118
    [Abstract] [Full Text] [Related]

  • 34. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER, Sutherland WH, Temple Wa.
    N Z Med J; 1980 Nov 12; 92(671):345-9. PubMed ID: 6935550
    [Abstract] [Full Text] [Related]

  • 35. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
    Arntz HR, Klemens UH, Vollmar LJ, Lang PD.
    Med Klin; 1978 Dec 08; 73(49):1731-7. PubMed ID: 723760
    [Abstract] [Full Text] [Related]

  • 36. Dietary and drug treatment of hyperlipidaemia. A feasibility study in asymptomatic middle-aged men.
    Hedstrand H.
    Ups J Med Sci; 1976 Dec 08; 81(2):85-92. PubMed ID: 183322
    [Abstract] [Full Text] [Related]

  • 37. Diet and drug therapy for hyperlipoproteinemia.
    Maha GE.
    Med Times; 1971 Aug 08; 99(8):49-63 passim. PubMed ID: 5566828
    [No Abstract] [Full Text] [Related]

  • 38. The dyslipoproteinemias.
    Brown DF.
    Acta Diabetol Lat; 1972 Dec 08; 9 Suppl 2():18-52. PubMed ID: 4369284
    [No Abstract] [Full Text] [Related]

  • 39. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Artery; 1980 Dec 08; 8(2):113-9. PubMed ID: 7458676
    [Abstract] [Full Text] [Related]

  • 40. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982 Dec 08; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.